|
Wednesday, December 8, 2021, San Antonio, TX, 7:00 PM – 9:00 PM Central Time (8:00 PM – 10:00 PM Eastern Time)
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of HER2-Positive Breast Cancer (Part 2 of a 3-Part Series)A CME Satellite Symposium Held in Conjunction with SABCS®2021
Location
San Antonio Marriott Rivercenter 101 Bowie St San Antonio, TX 78205 Hotel Phone: (210) 223-1000 Program Schedule — Central Time 6:30 PM – 7:00 PM — Registration and Dinner 7:00 PM – 9:00 PM — Educational Meeting Meeting Room Grand Ballroom G-M (3rd floor) This event will also be webcast live. Please see Registration tab for details. Faculty
Carey K Anders, MD Professor of Medicine Medical Director of the Duke Center of Brain and Spine Metastases Duke Cancer Institute Durham, North Carolina Virginia F Borges, MD, MMSc Professor of Medicine with Tenure John C and Patricia Young-Connor Endowed Chair in Young Women’s Breast Cancer Deputy Head, Division of Medical Oncology Director, Breast Cancer Research Program and Young Women’s Breast Cancer Translational Program University of Colorado Cancer Center Aurora, Colorado Sara Hurvitz, MD Professor of Medicine David Geffen School of Medicine at UCLA Director, Breast Cancer Clinical Research Program Co-Director, Santa Monica-UCLA Outpatient Oncology Practice Santa Monica, California Ian E Krop, MD, PhD Associate Chief, Division of Breast Oncology Dana-Farber Cancer Institute Associate Professor of Medicine Harvard Medical School Boston, Massachusetts Moderator Lisa Carey, MD Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research Deputy Director of Clinical Sciences Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill, North Carolina This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, Merck, Puma Biotechnology Inc and Seagen Inc.
Program Schedule — Central Time 6:30 PM – 7:00 PM — Registration and Dinner 7:00 PM – 9:00 PM — Educational Meeting MODULE 1: Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer (BC) MODULE 2: Optimizing the Management of HER2-Positive Metastatic BC MODULE 3: Treatment of HER2-Positive Brain Metastases MODULE 4: Future Directions in the Management of HER2-Positive Localized and Metastatic BC MODULE 5: Incidence and Management of Adverse Events Associated with HER2-Targeted Therapy Target Audience
CME Credit Form FACULTY — The following faculty reported relevant financial relationships with ineligible entities: Dr Anders — Consulting Agreements: AstraZeneca Pharmaceuticals LP, Athenex, Eisai Inc, Elucida Oncology Inc, Genentech, a member of the Roche Group, Immunomedics Inc, Ipsen Biopharmaceuticals Inc, Novartis, Seagen Inc; Contracted Research: G1 Therapeutics Inc, Lilly, Merck, Nektar, Novartis, Pfizer Inc, Puma Biotechnology Inc, Seagen Inc, Tesaro, A GSK Company, The Zion Pharma; Royalties: Jones and Bartlett Learning. Dr Borges — Consulting Agreement: Seagen Inc; Contracted Research: Agendia Inc, AstraZeneca Pharmaceuticals LP, Merck, Pfizer Inc, Seagen Inc. Dr Hurvitz — Contracted Research Paid to Institution: Ambrx, Amgen Inc, Arvinas, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, CytomX Therapeutics, Daiichi Sankyo Inc, Dignitana AB, Genentech, a member of the Roche Group, Gilead Sciences Inc, GlaxoSmithKline, Immunomedics Inc, Lilly, MacroGenics Inc, Novartis, OBI Pharma Inc, Pfizer Inc, Phoenix Molecular Designs, Pieris Pharmaceuticals Inc, Puma Biotechnology Inc, Radius Health Inc, Sanofi Genzyme, Seagen Inc, Zymeworks Inc. Dr Krop — Consulting Agreements: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Celltrion, Context Therapeutics, Daiichi Sankyo Inc, Genentech, a member of the Roche Group, MacroGenics Inc, Seagen Inc, Taiho Oncology Inc; Contracted Research: Genentech, a member of the Roche Group, MacroGenics Inc, Pfizer Inc; Data and Safety Monitoring Board/Committee: Merck, Novartis.MODERATOR — Lisa Carey, MD – No relevant conflicts of interest to disclose. Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersThis activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, Merck, Puma Biotechnology Inc and Seagen Inc. San Antonio Marriott Rivercenter Thank you for your interest in our CME program. At this time online preregistration is closed for this event. SEATS ARE STILL AVAILABLE FOR THE SESSION. Our Onsite Registration Desk will be open at 6:30 PM on Wednesday, December 8th. If you are interested in attending, please visit our registration desk located outside the Grand Ballroom G-M (Third Floor) of the Marriott Rivercenter hotel (101 Bowie St) within walking distance of the Henry B Gonzalez Convention Center. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. NOTICE: Registration for this event is independent of registration for the SABCS Conference. Registration for live broadcast
Please note we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. Registration for Webcast »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.
|